• ICH GCP
    • Dansk
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Magyar
    • Nederlands
    • Norsk
    • Polski
    • Português
    • Suomi
    • Svenska
    • Čeština
    • Русский
    • 日本語
    • 简体中文
    • 한국어
  • Regulations
    • USA (FDA)
    • UK (MHRA)
    • AUSTRALIA (NHMRC)
    • JAPAN (PMDA)
  • CRO List
  • Clinical Trials
    • US Clinical Trials Registry
    • EU Clinical Trials Registry
    • Pharmaceutical Companies
    • Clinical Research Labs
    • Clinical Research Events
    • Publications
    • Researchers
  • Jobs
  • Publications
  • News
  • Regulations
    • GLOBAL (ICH GCP)
    • USA (FDA)
    • UK (MHRA)
    • AUSTRALIA (NHMRC)
    • JAPAN (PMDA)
    • EU (EMA)
  • CRO List
  • Clinical Trials
    • US Clinical Trials Registry
    • EU Clinical Trials Registry
    • Pharmaceutical Companies
    • Clinical Research Labs
    • Service Companies
    • Clinical Research Events
    • Publications
    • Researchers
  • Jobs
  • Publications
  • News
Example: Heart Attack
  • Glossary
  • Understanding Clinical Trials

Search clinical trials for: Complement Factor B

Total 10000 results


  • NCT07187401
    Recruiting
    A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor
    Paroxysmal Nocturnal Hemoglobinuria (PNH) | Persistent Anemia
  • NCT06723132
    Not yet recruiting
    A Retrospective Study of Prognostic Factors and Survival of Breast Cancer Patients with Brain Metastesis
    Breast Cancer
  • NCT04434092
    Active, not recruiting
    A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors (COMMODORE 2)
    Paroxysmal Nocturnal Hemoglobinuria
  • NCT04432584
    Active, not recruiting
    A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors (COMMODORE 1)
    Paroxysmal Nocturnal Hemoglobinuria
  • NCT05116787
    Terminated
    BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants Not Receiving Other Complement Inhibitor Therapy (REDEEM-2)
    Paroxysmal Nocturnal Hemoglobinuria (PNH)

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.

«Manage Settings
Regulations
  • GLOBAL (ICH GCP)
  • USA (FDA)
  • UK (MHRA)
  • AUSTRALIA (NHMRC)
  • JAPAN (PMDA)
  • EU (EMA)
Resources
  • CRO List
  • Pharmaceutical Companies
  • Clinical Research Labs
  • Service Companies
  • Jobs
  • US Clinical Trials Registry
  • EU Clinical Trials Registry
Articles
  • Publications
  • News
  • About us / Our mission
Language
Dansk Deutsch English Español Français Italiano Magyar Nederlands Norsk Polski Português Suomi Svenska Čeština Русский 日本語 简体中文 한국어
  • Sitemap
  • Contact us
  • RSS feed
  • Privacy Policy
  • Disclaimer
© ICH GCP. All Rights Reserved.